Endocannabinoid-related lipids are increased during an episode of cyclic vomiting syndrome.
about
Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and VomitingCirculating Endocannabinoids: From Whence Do They Come and Where are They Going?Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline.Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome.Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPARα and CB1 receptors.
P2860
Endocannabinoid-related lipids are increased during an episode of cyclic vomiting syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Endocannabinoid-related lipids ...... e of cyclic vomiting syndrome.
@en
Endocannabinoid-related lipids ...... e of cyclic vomiting syndrome.
@nl
type
label
Endocannabinoid-related lipids ...... e of cyclic vomiting syndrome.
@en
Endocannabinoid-related lipids ...... e of cyclic vomiting syndrome.
@nl
prefLabel
Endocannabinoid-related lipids ...... e of cyclic vomiting syndrome.
@en
Endocannabinoid-related lipids ...... e of cyclic vomiting syndrome.
@nl
P2093
P2860
P356
P1476
Endocannabinoid-related lipids ...... e of cyclic vomiting syndrome.
@en
P2093
C J Hillard
T Venkatesan
Y Zadvornova
P2860
P304
P356
10.1111/NMO.12843
P577
2016-04-20T00:00:00Z